News

You’re invited! Join the 1st CARE Registry Korean Virtual Information Session! 

By Commentary, Community Events, UCI MIND

  Did you know that Asians, including Korean Americans are among the least represented groups in health research? CARE stands for “Collaborative Approach for Asian Americans & Pacific Islanders Research & Education”. The goal of the CARE Registry is to connect Asian Americans and Pacific Islanders to various types of research that may make a difference in improving the health of you, your family and future generations. Please join Dr. Hye-Won Shin, Director of Asian American Outreach of UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND), and CARE Community Advisory Board member for the 1st CARE Registry Korean Virtual Information Session! This session will be offered…

The post You’re invited! Join the 1st CARE Registry Korean Virtual Information Session!  appeared first on UCI MIND.

Read More

A December to Remember is tomorrow!

By Commentary, Community Events, In the News, UCI MIND

Tomorrow A December to Remember Gala, presented by UCI MIND and the Harris Taylor Family, is tomorrow! We look forward to an evening of music, magic, and memories for Alzheimer’s research.   Pre-Show at 5:30 PM PST Live Program at 6:00 – 7:00 PM PST   Three Viewing Options: YouTube Live (watch on your Smart TV) Facebook Live (interact with other viewers) Gala Website (quick access to auction items)   Live Stream Link   Silent Auction The gala auction is now live and closes Monday, December 7 at 12:00 PM PST. Two Ways to Bid: Visit mind.uci.edu/bid Text MIND to 61094   View Auction   Presenting Sponsor Harris…

The post A December to Remember is tomorrow! appeared first on UCI MIND.

Read More

4 questions to ask yourself about living to 100 — because there’s a chance you will

By Carousel Slider, In the News, UCI MIND

MarketWatch – Nov. 30, 2020 The University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) has studied elderly individuals as part of its “90+ Study” since 2003, analyzing the ways in which nearly 2,000 participants go about their lives in their 90s and 100s, as well as what may have contributed to that longevity and underlying cognitive disabilities they may or may not know they have. … Half of children born this decade can expect to see their 103rd or 104th birthday, Claudia Kawas, co-principal investigator of The 90+ Study, told CBS. Read more >

The post 4 questions to ask yourself about living to 100 — because there’s a chance you will appeared first on UCI MIND.

Read More

We need the power of our community

By Commentary, Community Events, UCI MIND

Today is Giving Tuesday, a celebration of generosity and philanthropy, and a global movement to harness the power of community for the greater good. At UCI MIND, we rely on the support of our community to advance life-changing research and continue the fight against Alzheimer’s disease, a debilitating illness that impacts more than 5.8 million Americans and their families. This Giving Tuesday, we hope you will expand our capacity to conduct promising research and accelerate progress toward a world without Alzheimer’s disease by supporting the Alzheimer’s Disease Excellence Fund. Our goal is to rid the world of Alzheimer’s disease. We…

The post We need the power of our community appeared first on UCI MIND.

Read More

Today is Giving Tuesday!

By Commentary, Community Events, UCI MIND

Today is Giving Tuesday, and UCI MIND could use your help during this year’s international day of philanthropy. We hope you will support us by: Staying connected! Visit this link for ways to follow UCI MIND and keep informed of brain health, Alzheimer’s disease and related dementia research. Making a gift! Click here to donate to the Alzheimer’s Disease Excellence Fund. Your donation of any amount will help advance research into the treatment, prevention, diagnosis and care for Alzheimer’s disease and related dementias. At UCI MIND, our goal is to rid the world of Alzheimer’s disease. We need the power…

The post Today is Giving Tuesday! appeared first on UCI MIND.

Read More

UCI Spearheads $109M Down Syndrome, Alzheimer’s Study

By Carousel Slider, Commentary, In the News, UCI MIND

The University of California, Irvine is undertaking a five-year, multi-million dollar project to expand research on Alzheimer’s disease in people with Down syndrome. The National Institute of Health awarded a $109 million grant to the Alzheimer’s Biomarkers Consortium-Down Syndrome in late October. The international team, led by UCI principal investigators Elizabeth Head and Mark Mapstone, aims to identify biomarkers that indicate the progression of Alzheimer’s disease in adults with Down syndrome. Subscribers to the Orange County Business Journal can read more here >          

The post UCI Spearheads $109M Down Syndrome, Alzheimer’s Study appeared first on UCI MIND.

Read More

Governor’s Task Force on Alzheimer’s Prevention and Preparedness

By Commentary, In the News, UCI MIND

Dear friends of UCI MIND, Last week, Maria Shriver and the Governor’s Task Force on Alzheimer’s Prevention and Preparedness presented a report describing their 10 recommendations to Governor Gavin Newsom. Click here to view the report. The Governor was extremely receptive to the recommendations. We anticipate movement in the coming months to years on these important initiatives to improve the lives of Californians living with dementia and their families and to increase Alzheimer’s awareness, risk reduction education, and research. We would like to thank the many UCI MIND stakeholders who participated in the Task Force listening session as part of…

The post Governor’s Task Force on Alzheimer’s Prevention and Preparedness appeared first on UCI MIND.

Read More

Holidays during COVID-19

By Clinical Trials, Commentary, COVID-19, Longitudinal Cohort, Participants, UCI MIND

Have you noticed the Holiday decorations popping up at shopping malls already? Yes, the Holiday Season is upon us. This year, due to the COVID-19 pandemic, we all need to carefully plan our social gatherings, meals, and guests in our homes. Hopefully, you will find some helpful hints here so you can safely navigate all the Holidays you will celebrate this year.   The very best gift you can give yourself, your loved ones and your friends is to make sure you get your flu vaccine as soon as possible. Keep in mind that grocery stores and malls will be getting…

The post Holidays during COVID-19 appeared first on UCI MIND.

Read More

Cartographers of the brain

By Carousel Slider, Commentary, In the News, UCI MIND

Contributed by UCI News: UCI’s Center for Neural Circuit Mapping is redrawing our understanding of mechanisms underlying several common disorders by Ian Anzlowar, UCI | November 18, 2020 Thanks to Xiangmin Xu and his team at the UCI School of Medicine’s Center for Neural Circuit Mapping, lazy eye, Alzheimer’s and other neurological diseases could become a thing of the past. Opened earlier this year, the unit focuses on basic neuroscience research, advancing knowledge of the brain by defining mechanisms and pathways that underlie neurodevelopmental, neuropsychiatric and neurodegenerative disorders. “Our 30 to 40 investigators can join forces to tackle large-scale research…

The post Cartographers of the brain appeared first on UCI MIND.

Read More

Deep Sleep Protects Against Alzheimer’s Disease, Growing Evidence Shows

By Commentary, UCI MIND

Commentary on NPR article, contributed by Bryce Mander, PhD Numerous studies now show that multiple forms of sleep disturbance increase risk for developing dementia. Emerging work continues to demonstrate that the way in which the brain expresses sleep may be tied to how much Alzheimer’s disease (AD) pathology there is in the brain even prior to AD symptom onset. Both sleep restriction and suppression of high amplitude, low frequency brain waves – called slow waves – during deep sleep increase beta amyloid and tau, the two hallmark pathologies of AD. It is unknown how this occurs, though there is evidence of two potential mechanisms: increased production of AD…

The post Deep Sleep Protects Against Alzheimer’s Disease, Growing Evidence Shows appeared first on UCI MIND.

Read More

UCI C2C Registry now live in multiple languages

By Commentary, In the News, UCI MIND

In 2016, UCI MIND launched a local recruitment registry – the UCI Consent-to-Contact (C2C) Registry – to raise awareness of research participation opportunities at UCI (c2c.uci.edu). We are excited to announce that this fall, the UCI C2C went live in Spanish, Korean, Chinese, and Vietnamese to allow more people to access this online tool. Together with our diverse community, we will improve our understanding of Alzheimer’s disease and related dementias in diverse populations and find solutions for people of all backgrounds. To learn more about enrolling in C2C, visit c2c.uci.edu > To read more in our latest newsletter, click here >

The post UCI C2C Registry now live in multiple languages appeared first on UCI MIND.

Read More

MIND Matters | Quarterly Newsletter | Fall 2020

By Clinical Trials, Commentary, Community Events, COVID-19, In the News, Longitudinal Cohort, Participants, UCI MIND

Message from the Director   Dear Friends of UCI MIND, As the COVID-19 pandemic continues to impact our lives this fall, the fight to solve Alzheimer’s disease and related dementias (ADRD) must charge forward. This November, the U.S. FDA will convene an advisory committee to assess potential approval of Biogen’s aducanumab, a monoclonal antibody in development for treatment of early AD. We will watch closely as aducanumab could be the first new approved drug for AD since 2005. Regardless of the outcome of the meeting and subsequent FDA decision – anticipated in March 2021 – this represents a milestone for…

The post MIND Matters | Quarterly Newsletter | Fall 2020 appeared first on UCI MIND.

Read More

FDA Advisory Panel Recommends Against Approval of Aducanumab for the Treatment of Alzheimer’s Disease

By Commentary, In the News, UCI MIND

Many of us listened intently today as the US Food and Drug Administration convened a panel of expert members of an advisory committee to review the submitted materials for potential approval of Biogen’s candidate treatment for early Alzheimer’s disease, aducanumab. The meeting was notable on many levels. Advocates made clear and compelling demonstrations of why new therapies are so desperately needed for this disease. The experts, however, were equally clear that the available data from a still limited number of studies, only one of which was actually positive, do not meet the current standards for drug approval in the United…

The post FDA Advisory Panel Recommends Against Approval of Aducanumab for the Treatment of Alzheimer’s Disease appeared first on UCI MIND.

Read More
English